Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jgar.2021.12.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Emergence of NDM-1-Producing Nosocomial Isolates in Attica Region of Greece.
Microorganisms
August 2024
AMR and HAIs Laboratory, Central Public Health Laboratory, National Public Health Organization, Vari, 16672 Attica, Greece.
Here, we report on the emergence and spread of multidrug-resistant NDM-1-producing isolates from patients hospitalized in the Attica region, Greece, in 2022 to provide data on their resistome, their virulome, the genetic environment of , and their molecular epidemiology. A total of 17 carbapenem-resistant isolates identified as NDM-producers by immunochromatography at the hospital level were sent to the Central Public Health Laboratory, in the frame of the laboratory surveillance of carbapenem-resistant pathogens, for further characterization. The initial screening for genetic AMR determinants was carried out by PCR and the MDR Direct Flow Chip assay.
View Article and Find Full Text PDFSimultaneous clonal spread of NDM-1-producing ST773 from Ukrainian patients in the Netherlands and Spain.
IJID Reg
September 2024
Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Objectives: We describe the clonal spread of New Delhi metallo-β-lactamase (NDM) 1-producing isolates belonging to the ST773 clone in Spain and the Netherlands, associated with the transfer of Ukrainian patients during the war.
Methods: Between March and December 2022, nine NDM-1-producing ST773 isolates were recovered from nine Ukrainian patients evacuated to two Spanish ( = 3) and five Dutch ( = 6) hospitals. Antimicrobial susceptibility testing was studied (Sensititre, Microscan, EUCAST-2023).
Outbreak caused by multidrug-resistant OXA-48 and NDM-1 producing Klebsiella pneumoniae in the intensive care unit of a cancer hospital.
Acta Microbiol Immunol Hung
September 2024
1Department of Clinical Microbiology, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.
We report a nosocomial outbreak caused by a multidrug-resistant carbapenemase-producing Klebsiella pneumoniae (MDRCPKp), that was detected in six patients admitted to the medical intensive care unit between 20th of December 2023 and 15th of January 2024 in Ankara, Turkey. The investigation of this outbreak was started on 29th of December 2023. During the outbreak 11 samples were collected from the six patients with MDRCPKp.
View Article and Find Full Text PDFMolecular Characterization of a KPC-2- and NDM-1-Producing Clinical Isolate in Cerebrospinal Fluid.
Infect Drug Resist
August 2024
Department of Clinical Laboratory, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, People's Republic of China.
Article Synopsis
- A strain named fxq was isolated from a cerebrospinal fluid sample of a patient with tentorial meningioma, showcasing resistance to carbapenems due to the presence of KPC and NDM carbapenemase genes.
- Identification methods included the Phoenix 100 system, MALDI-TOF, and whole-genome sequencing, revealing that fxq is a novel sequence type (ST202) with specific plasmid characteristics.
- The study highlights the significant stability and transferability of the resistance plasmids, marking the first report of this particular resistant strain in a clinical setting.
Tracing the origin of NDM-1-producing and extensively drug-resistant Pseudomonas aeruginosa ST357 in the Netherlands.
BMC Infect Dis
August 2024
Department of Medical Microbiology and Infection Prevention, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
Background: In the hospital environment, carbapenemase-producing Pseudomonas aeruginosa (CPPA) may lead to fatal patient infections. However, the transmission routes of CPPA often remain unknown. Therefore, this case study aimed to trace the origin of CPPA ST357, which caused a hospital-acquired pneumonia in a repatriated critically ill patient suffering from Guillain-Barré Syndrome in 2023.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!